APA

Braselmann S., Taylor V., Zhao H., Wang S., Sylvain C., Baluom M., Qu K., Herlaar E., Lau A., Young C., Wong B. R., Lovell S., Sun T., Park G., Argade A., Jurcevic S., Pine P., Singh R., Grossbard E. B., Payan D. G. & Masuda E. S. (20070109). R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation. : The Journal of pharmacology and experimental therapeutics.

Chicago

Braselmann Sylvia, Taylor Vanessa, Zhao Haoran, Wang Su, Sylvain Catherine, Baluom Muhammad, Qu Kunbin, Herlaar Ellen, Lau Angela, Young Chi, Wong Brian R, Lovell Scott, Sun Thomas, Park Gary, Argade Ankush, Jurcevic Stipo, Pine Polly, Singh Rajinder, Grossbard Elliott B, Payan Donald G and Masuda Esteban S. 20070109. R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation. : The Journal of pharmacology and experimental therapeutics.

Harvard

Braselmann S., Taylor V., Zhao H., Wang S., Sylvain C., Baluom M., Qu K., Herlaar E., Lau A., Young C., Wong B. R., Lovell S., Sun T., Park G., Argade A., Jurcevic S., Pine P., Singh R., Grossbard E. B., Payan D. G. and Masuda E. S. (20070109). R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation. : The Journal of pharmacology and experimental therapeutics.

MLA

Braselmann Sylvia, Taylor Vanessa, Zhao Haoran, Wang Su, Sylvain Catherine, Baluom Muhammad, Qu Kunbin, Herlaar Ellen, Lau Angela, Young Chi, Wong Brian R, Lovell Scott, Sun Thomas, Park Gary, Argade Ankush, Jurcevic Stipo, Pine Polly, Singh Rajinder, Grossbard Elliott B, Payan Donald G and Masuda Esteban S. R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation. : The Journal of pharmacology and experimental therapeutics. 20070109.